ProCE Banner Activity

Expert Q&A – Current Topics in Obstructive Sleep Apnea: Treatment of Excessive Daytime Sleepiness

Text Module

During PCE's recent Pulmonary Bootcamp, attendees had the chance to ask our expert faculty a variety of questions. Here, Karl Doghramji, MD and Ann Cartwright, PA-C, faculty for the presentation Current Topics in Obstructive Sleep Apnea: Treatment of Excessive Daytime Sleepiness provide responses to the questions about excessive daytime sleepiness. We hope you will find their responses relevant to your practice.

In Partnership With the Association of Pulmonary Advanced Practice Providers


Released: December 10, 2021

Expiration: December 09, 2022



Ann Cartwright

Ann Cartwright, PA-C, MPAS

Physician Assistant/Instructor
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Colorado School of Medicine
UCHealth Sleep Medicine Clinic
Aurora, Colorado

Karl Doghramji

Karl Doghramji, MD

Karl Doghramji, MD
Professor of Psychiatry, Neurology, and Medicine
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania


This program is cosupported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Genentech, a member of the Roche Group; GlaxoSmithKline; Jazz Pharmaceuticals, Inc.; and Mylan Specialty L.P.

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Provided by

ProCE Banner


Ms Cartwright has no relevant financial relationships to disclose.

Dr Doghramji: consulting fees: Eisai, Idorsia, Imbrium, Pfizer; contracted research/consulting fees: Harmony, Jazz, Inspire; ownership interest: Merck.

Additional Information

Program Medium

This program has been made available online.